Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (Lucentis, Genentech, South San Francisco, Calif, USA) combined with cataract surgery for the prevention of clinically significant macular edema (CSME) in patients with diabetic retinopathy (DR). This prospective...

Full description

Bibliographic Details
Main Authors: Patricia Udaondo, Maria Garcia-Pous, Salvador Garcia-Delpech, David Salom, Manuel Diaz-Llopis
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2011/159436